Related Experiment Video
Updated: May 10, 2025
10:29
A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
Published on: March 24, 2017
7.7K
[Rifampicin-resistant tuberculosis prevention and control in Jiangsu Province from 2013 to 2023]
1Department of Chronic Communicable Disease Control and Prevention, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing 210009, China.
Summary
Rifampicin-resistant tuberculosis (TB) detection and treatment improved significantly in Jiangsu Province from 2013-2023. Control policies effectively increased treatment enrollment and success rates for drug-resistant TB patients.
Area of Science:
- Public Health
- Infectious Disease Epidemiology
- Tuberculosis Control
Context:
- Drug-resistant tuberculosis (TB) poses a significant global health challenge.
- Jiangsu Province has implemented various control policies and measures for drug-resistant TB.
- Understanding trends in detection, treatment, and outcomes is crucial for effective public health interventions.
Purpose:
- To analyze trends in rifampicin-resistant TB detection, treatment, and outcomes in Jiangsu Province (2013-2023).
- To assess the effectiveness of implemented control policies and measures.
- To provide evidence-based recommendations for improved drug-resistant TB control strategies.
Summary:
- Rifampicin-resistant TB patient numbers increased (1.45% annually) from 2013-2023.
- Screening rates and molecular testing for drug resistance rose, with a turning point in 2018.
- Treatment enrollment (12.91% increase post-2020) and success rates (9.94% increase post-2020) for rifampicin-resistant TB significantly improved.
Impact:
- Demonstrates the effectiveness of public health interventions in combating drug-resistant TB.
- Highlights successful policy implementation in improving TB patient outcomes.
- Provides valuable data for refining national and regional TB control strategies.
Related Concept Videos
01:28Pulmonary Tuberculosis V
150
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
150
01:26Pulmonary Tuberculosis IV
123
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
123
01:28Pulmonary Tuberculosis II
195
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
195
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
01:25Transmission-based Precautions II: Airborne and Protective Environment
1.2K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.2K